7PS-25026-32430
4 vaccinations
9 coded responses
23 check-ins
8 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 209 / MD
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-20
Dose 1 — Moderna
-
2021-03-20
Dose 2 — Moderna
-
2021-03-24
Registered in v-safe
-
2021-03-24
Survey response — days 1–6 daily, dose 2MedDRA: Ageusia, Cough, Depression, Dyspnoea, Feeling abnormal, Oropharyngeal pain, Vision blurred — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaFree text: coughing, shortness of breath, fuzzy brain, depression, no taste, sore throat, vision blurredMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Feeling abnormal, Vision blurred — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: coughing, brain fog, blurry visionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-27
Survey response — day 7, dose 2MedDRA: Cough — Feeling: Good · Fatigue or tiredness, NauseaFree text: mild coughingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-05
- 2021-04-11
- 2021-04-17
- 2021-04-24
- 2021-05-01
-
2022-03-17
Dose 3 — Moderna
-
2022-04-29
Survey response — day 42, dose 3MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: COVID infection with positive home test, 2/20/2022 - 3/8/2022 COVID infection with positive home test, 4/25/2022 - presentMedDRA releases: 2024-11 · check-in free text available
-
2022-04-29
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-05-03
-
2022-06-20
Survey response — 3 months, dose 3MedDRA: Ageusia, Brain fog, Chills, Constipation, Cough, Decreased appetite, Diarrhoea, Dizziness, Fatigue, Headache, Nausea, Oropharyngeal pain, Pain, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Runny nose, headache, fever, chills, diarrhea/constipation, nausea, achiness, dizziness (moderate to severe), tiredness, loss of taste/appetite, sore throat, coughing, memory fogMedDRA releases: 2024-11 · check-in free text available
-
2022-10-05
Dose 4 — Moderna
-
2022-10-07
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-10-08
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2022-10-09
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-10
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-11
Survey response — days 1–6 daily, dose 4MedDRA: Anxiety — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolFree text: AnxietyMedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Survey response — day 7, dose 4MedDRA: Anxiety — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolFree text: AnxietyMedDRA releases: 2024-11 · check-in free text available
- 2022-10-19
-
2022-10-29
Survey response — day 21, dose 4MedDRA: Chills, Cough, Headache, Influenza, Nasopharyngitis, Nausea, Pain, Sneezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Severe cold/flu symptoms. Chills. Nausea. Aching. Sneezing, coughing. HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2022-11-02
- 2022-11-09
- 2023-01-06
-
2023-04-07
Survey response — 6 months, dose 4MedDRA: Adenovirus infection, Asthma, Blood glucose increased, Blood pressure increased, Cough, Dyspnoea, Headache, Hospitalisation, Pre-existing disease, Rehabilitation therapy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-04-07
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2023-04-11
Call successfulCompleted over the phone
-
2023-04-11
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-20 | Moderna | |
| 2 | 2021-03-20 | Moderna | |
| 3 | 2022-03-17 | Moderna | No |
| 4 | 2022-10-05 | Moderna | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 2
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): coughing, shortness of breath, fuzzy brain, depression, no taste, sore throat, vision blurred
Systemic reaction (other): coughing, brain fog, blurry vision
Release 6 — day 7, dose 2
Systemic reaction (other): mild coughing
Release 11 — day 42, dose 3
Symptoms: COVID infection with positive home test, 2/20/2022 - 3/8/2022 COVID infection with positive home test, 4/25/2022 - present
Release 12 — 3 months, dose 3
Symptoms: Runny nose, headache, fever, chills, diarrhea/constipation, nausea, achiness, dizziness (moderate to severe), tiredness, loss of taste/appetite, sore throat, coughing, memory fog
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Anxiety
Release 12 — day 7, dose 4
Systemic reaction (other): Anxiety
Release 12 — day 21, dose 4
Symptoms: Severe cold/flu symptoms. Chills. Nausea. Aching. Sneezing, coughing. Headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Hospitalisation | · | · | ✓ |
| HCVO | Rehabilitation therapy | · | · | ✓ |
| SD | Adenovirus infection | · | · | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Blood glucose increased | · | · | ✓ |
| SD | Blood pressure increased | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Constipation | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Ageusia | ✓ | ✓ | ✓ |
| SRO | Anxiety | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Depression | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release